GTC
RETA
Ghost Tree Capital’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-85,000
| Closed | -$8.67M | – | 75 |
|
2023
Q2 | $8.67M | Buy |
85,000
+15,000
| +21% | +$1.53M | 2.86% | 12 |
|
2023
Q1 | $6.36M | Sell |
70,000
-430,000
| -86% | -$39.1M | 1.88% | 18 |
|
2022
Q4 | $19M | Sell |
500,000
-225,000
| -31% | -$8.55M | 8.11% | 1 |
|
2022
Q3 | $18.2M | Buy |
+725,000
| New | +$18.2M | 5.11% | 2 |
|
2022
Q1 | – | Sell |
-55,000
| Closed | -$1.45M | – | 50 |
|
2021
Q4 | $1.45M | Buy |
+55,000
| New | +$1.45M | 0.52% | 41 |
|
2020
Q4 | – | Sell |
-30,000
| Closed | -$2.92M | – | 55 |
|
2020
Q3 | $2.92M | Sell |
30,000
-20,000
| -40% | -$1.95M | 0.84% | 32 |
|
2020
Q2 | $7.8M | Hold |
50,000
| – | – | 2.06% | 18 |
|
2020
Q1 | $7.22M | Sell |
50,000
-25,000
| -33% | -$3.61M | 1.91% | 12 |
|
2019
Q4 | $15.3M | Buy |
75,000
+25,000
| +50% | +$5.11M | 2.92% | 7 |
|
2019
Q3 | $4.02M | Buy |
+50,000
| New | +$4.02M | 1.02% | 27 |
|